Two Sigma Investments
BBH icon

Two Sigma Investments’s VanEck Biotech ETF BBH Stock Holding History

Two Sigma Investments’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Sell
6,100
-5,700
-48% -$1.1M ﹤0.01% 3163
2025
Q4 		$2.23M Buy
+11,800
New +$2.18M ﹤0.01% 2356
2025
Q1 		– Sell
-1,900
Closed -$298K – 3202
2024
Q4 		$298K Sell
1,900
-700
-27% -$118K ﹤0.01% 2736
2024
Q3 		$461K Buy
+2,600
New +$461K ﹤0.01% 2511

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Two Sigma Investments's BBH Position: Q1 2026 in Review

Two Sigma Investments reduced its VanEck Biotech ETF (BBH) stake by 48% in Q1 2026, selling an estimated $1.1M and leaving 6,100 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3163.

Two Sigma Investments first reported a position in BBH in Q3 2024 and has held it in 4 quarters since. The position peaked at $2.23M in Q4 2025. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Two Sigma Investments held 6,100 shares of VanEck Biotech ETF worth $1.15M as of Q1 2026.
  • Two Sigma Investments sold 5,700 VanEck Biotech ETF shares in Q1 2026, an estimated $1.1M.
  • VanEck Biotech ETF made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3163 holding.
  • Two Sigma Investments first reported a position in VanEck Biotech ETF in Q3 2024 and has held it in 4 quarters since.
  • Two Sigma Investments's VanEck Biotech ETF position peaked at $2.23M in Q4 2025.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.